Princeton Alpha Management’s Myriad Genetics MYGN Stock Holding History

Princeton Alpha Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-23,940	Closed	-$399K	–	682
2016 Q4	$399K	Buy	+23,940	New	+$433K	0.08%	376
2016 Q3	–	Sell	-20,269	Closed	-$620K	–	870
2016 Q2	$620K	Buy	+20,269	New	+$704K	0.11%	287
2014 Q3	–	Sell	-22,952	Closed	-$893K	–	774
2014 Q2	$893K	Buy	22,952 +13,880	+153%	+$516K	0.18%	166
2014 Q1	$310K	Buy	+9,072	New	+$281K	0.1%	338

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Princeton Alpha Management's MYGN Position: Q1 2017 in Review

Princeton Alpha Management sold out of Myriad Genetics (MYGN) in Q1 2017, closing a stake of 23,940 shares — an estimated $399K sold.

Princeton Alpha Management first reported a position in MYGN in Q1 2014 and held it in 4 quarters. The position peaked at $893K in Q2 2014. 233 funds tracked by Wall St. Rank hold MYGN as of Q1 2017.

Princeton Alpha Management reported no remaining Myriad Genetics position as of Q1 2017 after selling out during the quarter.
Princeton Alpha Management sold 23,940 Myriad Genetics shares in Q1 2017, an estimated $399K.
Princeton Alpha Management first reported a position in Myriad Genetics in Q1 2014 and held it in 4 quarters.
Princeton Alpha Management's Myriad Genetics position peaked at $893K in Q2 2014.
233 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.